Company / Operating Cash Flow per Share
RIGEL PHARMACEUTICALS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$4.27
FY2025
5-year range
-$0.43 / $4.27
FY2021-FY2025
Trend
+137.3%
vs FY2024
Sector context
#26 of 212
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's operating cash flow per share of $4.27 is higher than 88% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has increased for 3 consecutive years, from $-0.43 in FY2022 to $4.27 in FY2025.
Based on SEC 10-K filings.
4.27 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.03 to $4.27 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-19.0% below sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 137.3% year-over-year.
- Ranks #26 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.27 | +137.3% |
| FY2024 | $1.80 | +5535.2% |
| FY2023 | -$0.03 | +92.3% |
| FY2022 | -$0.43 | -1338.1% |
| FY2021 | $0.03 | +111.2% |
| FY2020 | -$0.31 | -25.1% |
| FY2019 | -$0.25 | +52.0% |
| FY2018 | -$0.52 | +15.8% |
| FY2017 | -$0.61 | +23.6% |
| FY2016 | -$0.80 | -203.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026